• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Marvin Zelen, PhD


  • Kalager M, Zelen M, Langmark F, Adami HO.Effect of screening mammography on breast-cancer mortality in Norway.N Engl J Med. 2010 Sep 23;363(13):1203-10.
  • Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ, .Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.Ann Intern Med. 2009 Nov 17;151(10):738-47.
  • Lee SJ, Zelen M.Mortality Modeling of Early Detection Programs.Biometrics. 2008 Jun;64(2):386-95.
  • Lee S, Zelen M.A stochastic model for predicting the mortality of breast cancer.J Natl Cancer Inst Monogr. 2006(36):79-86.
  • Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ,.Effect of screening and adjuvant therapy on mortality from breast cancer.N Engl J Med. 2005 Oct 27;353(17):1784-92.
  • Hu P, Zelen M.Experimental design issues for the early detection of disease: novel designs.Biostatistics. 2002 Sep;3(3):299-313.
  • Davidov O, Zelen M.Referent sampling, family history and relative risk: the role of length-biased sampling.Biostatistics. 2001 Jun;2(2):173-81.
  • Davidov O, Zelen M.The theory of case-control studies for early detection programs.Biostatistics. 2003 Jul;4(3):411-21.
  • Lee SJ, Zelen M.Modelling the early detection of breast cancer.Ann Oncol. 2003 Aug;14(8):1199-202.
  • Lee SJ, Zelen M.Statistical models for screening: planning public health programs.Cancer Treat Res. 2002;113:19-36.
  • Zelen M, Lee SJ.Models and the early detection of disease: methodological considerations.Cancer Treat Res. 2002;113:1-18.
  • Parmigiani G, Skates S, Zelen M.Modeling and optimization in early detection programs with a single exam.Biometrics. 2002 Mar;58(1):30-6.
  • Shen Y, Wu D, Zelen M.Testing the independence of two diagnostic tests.Biometrics. 2001 Dec;57(4):1009-17.
  • Shen Y, Zelen M.Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations.J Clin Oncol. 2001 Aug 1;19(15):3490-9.
  • Nam CM, Zelen M.Comparing the survival of two groups with an intermediate clinical event.Lifetime Data Anal. 2001 Mar;7(1):5-19.
  • Davidov O, Zelen M.Designing cancer prevention trials: a stochastic model approach.Stat Med. 2000 Aug 15;19(15):1983-95.
  • Davidov O, Zelen M.Exact tests for exponential regression.Journal of Statistical Planning and Inference. 2000 Jul 01;88(1):87-97.
  • Lee SJ, Zelen M.Clinical trials and sample size considerations: another perspective.Statistical Science. 2000 May 01;15(2):95-110.
  • Davidov O, Zelen M.Urn sampling and the proportional hazard model.Lifetime Data Anal. 1998;4(4):309-27.
  • Zelen M, Parker RA.Case-control studies and Bayesian inference.Stat Med. 1986 May-Jun;5(3):261-9.